Suppr超能文献

在雷特自然史研究中,四种发育性脑病的核心特征比较。

Comparison of Core Features in Four Developmental Encephalopathies in the Rett Natural History Study.

机构信息

Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania.

Division of Child Neurology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.

出版信息

Ann Neurol. 2020 Aug;88(2):396-406. doi: 10.1002/ana.25797. Epub 2020 Jun 29.

Abstract

OBJECTIVE

Rett syndrome, CDKL5-deficiency disorder, FOXG1 disorder, and MECP2 duplication disorder are developmental encephalopathies with shared and distinct features. Although they are historically linked, no direct comparison has been performed. The first head-to-head comparison of clinical features in these conditions is presented.

METHODS

Comprehensive clinical information was collected from 793 individuals enrolled in the Rett and Rett-Related Disorders Natural History Study. Clinical features including clinical severity, regression, and seizures were cross-sectionally compared between diagnoses to test the hypothesis that these are 4 distinct disorders.

RESULTS

Distinct patterns of clinical severity, seizure onset age, and regression were present. Individuals with CDKL5-deficency disorder were the most severely affected and had the youngest age at seizure onset (2 months), whereas children with MECP2 duplication syndrome had the oldest median age at seizure onset (64 months) and lowest severity scores. Rett syndrome and FOGX1 were intermediate in both features. Smaller head circumference correlates with increased severity in all disorders and earlier age at seizure onset in MECP2 duplication syndrome. Developmental regression occurred in all Rett syndrome participants (median = 18 months) but only 23 to 34% of the other disorders. Seizure incidence prior to the baseline visit was highest for CDKL5 deficiency disorder (96.2%) and lowest for Rett syndrome (47.5%). Other clinical features including seizure types and frequency differed among groups.

INTERPRETATION

Although these developmental encephalopathies share many clinical features, clear differences in severity, regression, and seizures warrant considering them as unique disorders. These results will aid in the development of disease-specific severity scales, precise therapeutics, and future clinical trials. ANN NEUROL 2020;88:396-406.

摘要

目的

雷特综合征、CDKL5 缺乏症、FOXG1 综合征和 MECP2 重复综合征是具有共同和不同特征的发育性脑病。虽然它们在历史上有联系,但没有进行过直接比较。本文首次对头对头比较这些疾病的临床特征。

方法

从雷特综合征和相关疾病自然史研究中招募的 793 名患者中收集了全面的临床信息。对这些诊断的临床严重程度、退化和癫痫发作进行了横断面比较,以检验这些疾病是 4 种不同疾病的假设。

结果

存在不同模式的临床严重程度、癫痫发作年龄和退化。CDKL5 缺乏症患者的病情最严重,癫痫发作年龄最小(2 个月),而 MECP2 重复综合征患儿癫痫发作年龄中位数最大(64 个月),严重程度评分最低。雷特综合征和 FOGX1 则处于两者之间。所有疾病的头围越小与严重程度越高以及 MECP2 重复综合征的癫痫发作年龄越小呈正相关。发育性退化发生在所有雷特综合征患者中(中位数=18 个月),但只有 23%至 34%的其他疾病患者出现这种情况。在基线检查之前,CDKL5 缺乏症的癫痫发作发生率最高(96.2%),而雷特综合征的发生率最低(47.5%)。其他临床特征,包括癫痫发作类型和频率,在各组之间存在差异。

结论

尽管这些发育性脑病有许多共同的临床特征,但严重程度、退化和癫痫发作的明显差异表明它们是不同的疾病。这些结果将有助于制定疾病特异性严重程度量表、精确治疗方法和未来临床试验。

相似文献

1
Comparison of Core Features in Four Developmental Encephalopathies in the Rett Natural History Study.
Ann Neurol. 2020 Aug;88(2):396-406. doi: 10.1002/ana.25797. Epub 2020 Jun 29.
2
Clinical and functional outcomes in pediatric patients with Rett syndrome: a 15-year retrospective study.
Eur J Pediatr. 2025 Jul 3;184(7):465. doi: 10.1007/s00431-025-06291-6.
4
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
5
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.
6
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3.
7
Prognosis of adults and children following a first unprovoked seizure.
Cochrane Database Syst Rev. 2023 Jan 23;1(1):CD013847. doi: 10.1002/14651858.CD013847.pub2.
8
The Black Book of Psychotropic Dosing and Monitoring.
Psychopharmacol Bull. 2024 Jul 8;54(3):8-59.
9
Antiepileptic drug monotherapy for epilepsy: a network meta-analysis of individual participant data.
Cochrane Database Syst Rev. 2022 Apr 1;4(4):CD011412. doi: 10.1002/14651858.CD011412.pub4.

引用本文的文献

1
Considerations and procedures for acquiring EEG as part of multi-site studies for Rett syndrome and other genetic neurodevelopmental disorders.
Front Integr Neurosci. 2025 Jun 9;19:1574758. doi: 10.3389/fnint.2025.1574758. eCollection 2025.
2
Molecular Insights into Neurological Regression with a Focus on Rett Syndrome-A Narrative Review.
Int J Mol Sci. 2025 Jun 3;26(11):5361. doi: 10.3390/ijms26115361.
3
Rett syndrome.
Nat Rev Dis Primers. 2024 Nov 7;10(1):84. doi: 10.1038/s41572-024-00568-0.
4
Developmental and epileptic encephalopathies.
Nat Rev Dis Primers. 2024 Sep 5;10(1):61. doi: 10.1038/s41572-024-00546-6.
5
CDKL5 Deficiency Disorder: Some Lessons Learned 20 Years After the First Description.
Am J Intellect Dev Disabil. 2024 Mar 1;129(2):101-109. doi: 10.1352/1944-7558-129.2.101.
6
Top caregiver concerns in Rett syndrome and related disorders: data from the US natural history study.
J Neurodev Disord. 2023 Oct 13;15(1):33. doi: 10.1186/s11689-023-09502-z.
7
CDKL5 deficiency disorder and other infantile-onset genetic epilepsies.
Dev Med Child Neurol. 2024 Apr;66(4):456-468. doi: 10.1111/dmcn.15747. Epub 2023 Sep 28.
8
Comparison of evoked potentials across four related developmental encephalopathies.
J Neurodev Disord. 2023 Mar 4;15(1):10. doi: 10.1186/s11689-023-09479-9.
9
GENE TARGET: A framework for evaluating Mendelian neurodevelopmental disorders for gene therapy.
Mol Ther Methods Clin Dev. 2022 Aug 29;27:32-46. doi: 10.1016/j.omtm.2022.08.007. eCollection 2022 Dec 8.
10
Factors influencing the attainment of major motor milestones in CDKL5 deficiency disorder.
Eur J Hum Genet. 2023 Feb;31(2):169-178. doi: 10.1038/s41431-022-01163-1. Epub 2022 Aug 18.

本文引用的文献

1
CDKL5 deficiency disorder: Relationship between genotype, epilepsy, cortical visual impairment, and development.
Epilepsia. 2019 Aug;60(8):1733-1742. doi: 10.1111/epi.16285. Epub 2019 Jul 16.
2
Severity Assessment in CDKL5 Deficiency Disorder.
Pediatr Neurol. 2019 Aug;97:38-42. doi: 10.1016/j.pediatrneurol.2019.03.017. Epub 2019 Mar 27.
3
Cyclin-Dependent Kinase-Like 5 Deficiency Disorder: Clinical Review.
Pediatr Neurol. 2019 Aug;97:18-25. doi: 10.1016/j.pediatrneurol.2019.02.015. Epub 2019 Feb 23.
4
Double-blind, randomized, placebo-controlled study of trofinetide in pediatric Rett syndrome.
Neurology. 2019 Apr 16;92(16):e1912-e1925. doi: 10.1212/WNL.0000000000007316. Epub 2019 Mar 27.
5
Characterizing the phenotypic effect of Xq28 duplication size in MECP2 duplication syndrome.
Clin Genet. 2019 May;95(5):575-581. doi: 10.1111/cge.13521. Epub 2019 Mar 15.
6
Delineating syndrome: From congenital microcephaly to hyperkinetic encephalopathy.
Neurol Genet. 2018 Nov 7;4(6):e281. doi: 10.1212/NXG.0000000000000281. eCollection 2018 Dec.
7
Epilepsy in classic Rett syndrome: Course and characteristics in adult age.
Epilepsy Res. 2018 Sep;145:134-139. doi: 10.1016/j.eplepsyres.2018.06.012. Epub 2018 Jun 23.
9
A Double-Blind, Randomized, Placebo-Controlled Clinical Study of Trofinetide in the Treatment of Rett Syndrome.
Pediatr Neurol. 2017 Nov;76:37-46. doi: 10.1016/j.pediatrneurol.2017.07.002. Epub 2017 Jul 8.
10
Distinguishing response to names in Rett and MECP2 Duplication syndrome: An ERP study of auditory social information processing.
Brain Res. 2017 Nov 15;1675:71-77. doi: 10.1016/j.brainres.2017.08.028. Epub 2017 Sep 1.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验